Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
All patients with the acquired immunodeficiency syndrome treated for their first episode of Pneumocystis carinii pneumonia at San Francisco General Hospital between 1 April 1985 and 15 July 1985 were evaluated for their response to treatment with dapsone (100 mg/day) by mouth for 21 days. Of 44 pati...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1988
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172343/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3263834/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.7.1057 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
